Diving deeper into Orphan Diseases – Marfan Syndrome (Part 2)
At Elastrin, there‘s something new every day.
Elastin Fiber antibodies guide the therapy to where it needs to be
Diving deeper into Orphan Diseases - Marfan Syndrome - Part 1
Elastrin Therapeutics DESTiNED Technology: A Nanoparticle Revolution
Chronic Obstructive Pulmonary Disease (COPD) / Lung Emphysema - Part 2
Chronic Obstructive Pulmonary Disease (COPD) / Lung Emphysema - Part 1
New review: Role of elastic fiber degradation in disease pathogenesis
Synthetic mRNA Therapies in Rare Diseases
Diving deeper into orphan diseases - Williams-Beuren Syndrome (WBS)
Diving deeper into orphan diseases - Generalized arterial calcification of infancy
Diving deeper into orphan diseases - Pseudoxanthoma elasticum
Using synthetic mRNA coding for Tropoelastin (TE) mRNA
An insight into orphan diseases and why research into those rare diseases matters!
Kizoo Portfolio Company Elastrin Therapeutics Inc. closes $10M Funding Round
Regenerative Medicine – Part 2
Interview with the SC Business Review
Elastrin Therapeutics Announces Newly Formed Scientific Advisory Board
Regenerative Medicine - Part 1
The World’s Deadliest Killer: The Heart
Winner @ InnoVision Awards 2021
Elastrin Therapeutics Inc. Closes Seed Funding Round with Kizoo Technology Capital